Early research (Phase 1)Ended earlyNCT02289482
What this trial is testing
A Single Dose Pharmacokinetic (PK) and Safety Study of GSK2838232 With and Without Ritonavir (RTV) Conducted in Healthy Subjects
Who this might be right for
Infection, Human Immunodeficiency Virus
GlaxoSmithKline 20